mutLBSgeneDB |
Gene summary for PTPN13 |
![]() |
Basic gene Info. | Gene symbol | PTPN13 |
Gene name | protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase) | |
Synonyms | FAP-1|PNP1|PTP-BAS|PTP-BL|PTP1E|PTPL1|PTPLE|hPTP1E | |
Cytomap | UCSC genome browser: 4q21.3 | |
Type of gene | protein-coding | |
RefGenes | NM_006264.2, NM_080683.2,NM_080684.2,NM_080685.2, | |
Description | fas-associated protein-tyrosine phosphatase 1hPTPE1protein-tyrosine phosphatase 1Eprotein-tyrosine phosphatase PTPL1tyrosine-protein phosphatase non-receptor type 13 | |
Modification date | 20141207 | |
dbXrefs | MIM : 600267 | |
HGNC : HGNC | ||
Ensembl : ENSG00000163629 | ||
HPRD : 02602 | ||
Vega : OTTHUMG00000160968 | ||
Protein | UniProt: Q12923 go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_PTPN13 | |
BioGPS: 5783 | ||
Pathway | NCI Pathway Interaction Database: PTPN13 | |
KEGG: PTPN13 | ||
REACTOME: PTPN13 | ||
Pathway Commons: PTPN13 | ||
Context | iHOP: PTPN13 | |
ligand binding site mutation search in PubMed: PTPN13 | ||
UCL Cancer Institute: PTPN13 | ||
Assigned class in mutLBSgeneDB | C: This gene just belongs to mutLBSgenes. |
![]() |
GO ID | GO Term | PubMed ID | GO:0006470 | protein dephosphorylation | 17657516 | GO:0014066 | regulation of phosphatidylinositol 3-kinase signaling | 23604317 |
Top |
Ligand binding site mutations for PTPN13 |
![]() |
LBS | AAchange of nsSNV | Cancer type | # samples | Q2310 | Q2310E | BRCA | 1 | C2408 | T2406M | UCEC | 1 |
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma. |
Top |
Protein structure related information for PTPN13 |
![]() Mupro score denotes assessment of the effect of mutations on thermodynamic stability. (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability) |
![]() ![]() |
![]() |
![]() Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene. |
LBS | AAchange of nsSNV | Relative stability change | C2408 | T2406M | -1.1262271 | Q2310 | Q2310E | -0.13933515 |
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132) |
![]() |
Top |
Differential gene expression and gene-gene network for PTPN13 |
![]() |
![]() |
Top |
Top |
Phenotype information for PTPN13 |
![]() |
Disease ID | Disease name | # PubMed | Association type |
umls:C0031117 | Peripheral Nervous System Diseases | 2 | Biomarker |
![]() |
Allele ID | AA change | Clinical significance | Origin | Phenotype IDs |
Top |
Pharmacological information for PTPN13 |
![]() Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient. |
![]() |
![]() |
Drug status | DrugBank ID | Name | Type | Drug structure |
![]() |
![]() |
![]() |
Ligand ID | Ligand short name | Ligand long name | PDB ID | PDB name | mutLBS | PO4 | PHOSPHATE ION | 1wch | A | C2408 | PO4 | PHOSPHATE ION | 1wch | A | Q2310 |
Top |
Conservation information for LBS of PTPN13 |
![]() |
LBS | AA sequence | # species | Species |
![]() |
Copyright © 2016-Present - The University of Texas Health Science Center at Houston |